Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
uniQure
Manufacturing
UniQure sells gene therapy manufacturing facility to Genezen
UniQure has sold its gene therapy manufacturing facility to Genezen, which will now supply uniQure’s clinical portfolio and produce CSL’s Hemgenix.
Kevin Dunleavy
Jul 1, 2024 10:46am
Pfizer charges $3.5M for its first FDA-approved gene therapy
Apr 26, 2024 10:19am
After Hemgenix approvals, uniQure inks $400M sale of royalties
May 15, 2023 3:10pm
New CEO Paul McKenzie plots CSL's course for growth
Apr 3, 2023 9:25am
CSL's hemophilia B gene therapy works well through 24 months
Dec 12, 2022 2:14pm
'The Top Line': Biogen's new CEO, plus this week's headlines
Dec 2, 2022 8:34am
